Skip to main content

letter

. 1995 Sep;40(3):287–288. doi: 10.1111/j.1365-2125.1995.tb05788.x

Tiracizine disposition in healthy volunteers with reference to the debrisoquine oxidation phenotype.

A Berndt, C Hoffmann, K Richter, R Oertel, A Vierkant, W Siegmund

PMCID: PMC1365113 PMID: 8527295

287

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Berndt A., Gramatté T., Oertel R., Richter K., Terhaag B., Kirch W. Dose dependent tiracizine disposition in healthy volunteers: serum and urine kinetics and dose related ECG-changes. Eur J Drug Metab Pharmacokinet. 1994 Oct-Dec;19(4):359–368. doi: 10.1007/BF03188863. [DOI] [PubMed] [Google Scholar]
Siegmund W., Hanke W., Zschiesche M., Franke G., Biebler K. E., Wilke A. N-acetylation and debrisoquine type oxidation polymorphism in Caucasians--with reference to age and sex. Int J Clin Pharmacol Ther Toxicol. 1990 Dec;28(12):504–509. [PubMed] [Google Scholar]
Volkmann H., Kühnert H., Dannberg G., Heinke M., Leeder U., Popp U. Elektrophysiologische und antiarrhythmische Effekte von Tiracizin bei ventrikulären Tachykardien. Z Gesamte Inn Med. 1991 Dec;46(17):635–641. [PubMed] [Google Scholar]

ACTIONS

RESOURCES